Tagged with M

Watson Pharmaceuticals Watson is one the largest generic players in the US but the international presence of the company is still relatively modest. Watson does not have commercial operations in India but you acquired Sekhsaria Chemicals back in 2006, as well as a formulations plant in Goa from Dr Reddy’s. Could you…

Contract Manufacturing The managing director of Encube Ethicals discusses contract manufacturing in India today, growing competition from China, and partnering with the world’s leading multinational pharma companies.   Mr Dilip Shah from the Indian Pharmaceutical Alliance told us that the main strength of India is manufacturing, so of course, contract manufacturing as…

Ferring Pharmaceuticals UK Shire’s International Marketing to being COO of start-up medical device company, Medicsight. What about Ferring and your current role attracted you to take this job and what are you bringing on board that is unique from your past experiences? As you mentioned, I have quite an extensive career and would…

Nycomed India While we have seen many MNCs becoming increasingly interested in India, the story of Nycomed has been quite unique. Rather than starting off with marketing and sales offices, India was chosen as the first global R&D centre outside of Europe. First of all, what sparked this early interest in Indian…

Materia Medica Focus Reports first met with Materia Medica in 2006. At the time, the company was enjoying an extremely rapid pace of growth. Looking back over the last years, how has the organization further developed? We have continued developing quite quicly. In the last few years, the company’s growth was 15–20%…

Lupin Pharmaceuticals Inc. Two weeks ago, Lupin announced its annual results, portraying 6 years of sustained growth and a net profit up by 27%. How pleased were you with this performance, and were you expecting such strong results? We were pleased, but not very pleased. We thought that we could have done much…

NATCO Pharma Compared to 5 years ago, MNCs have increased their presence in India. Some even have become market leaders, particularly through acquisitions of domestic players. How is this redistributing the game for local players? The Indian market structure is shaped in such way that no generic player gets big market shares.…

Bharat Biotech International Limited If we first take a step back and look at how Bharat Biotech was established, we see quite a remarkable story. It is rather exceptional to see scientists becoming entrepreneurs. What made you this exception, and what drove you to set up Bharat Biotech? I was based in the US…

S. Amit & Co India has experienced tremendous growth in its chemical and pharmaceutical industries. Being active for many years in the industry now, how have you seen the market evolving? S. Amit has been particularly active in supplying chemicals to the pharmaceutical industry, so my experience mainly stems from this field. In terms…

MSD pharmaceuticals Pvt. Ltd. While your appointment as Managing Director was not a long time ago, you immediately faced the big task to oversee one of the most complicated corporate mergers the local Indian drug industry has seen in recent years. How challenging was the integration of Fulford and Organon for you? One of…

IMEDA IMEDA was founded in 2005, and today counts amongst its members 28 leading international companies in the Russian medical technology sector. What are the main goals of the association today, and what battles is it fighting for its members? The main goal of our association is to represent the international…

Ministry of Health Voivodeships, Polish expenditure on health care system per one resident is still below the European average. In regards to the issue concerning the „expenditure on health care system”, I would like to inform you that the financial plan of the National Health Fund for 2011 provides that costs of health…